La profilassi dell’infezione neonatale da streptococco di gruppo B
ALBERTO BERARDI, KATIA ROSSI, CHIARA BUSSETTI, FABRIZIO FERRARI
Dipartimento di Scienze Ostetriche, Ginecologiche e Pediatriche, Sezione di Neonatologia,Università degli Studi di Modena e Reggio Emilia
PROPHYLAXIS OF NEONATAL GROUP B STREPTOCOCCAL INFECTION
Key words: Group B Streptococcus, Antibiotic prophylaxis, Screening
Group B Streptococcus is the leading cause of vertically transmitted neonatal bacterial infections.
The consequence of early and late-onset infections can be fatal diseases or severe
neurological sequelae, when central nervous system is involved. Many efforts have been made
on prevention, but the infection is not totally controlled. Bacteriological screening of all
mothers between the 35th and the 37th week of gestation, followed by maternal intrapartum
chemoprophylaxis (by penicillin or ampicillin) of colonised women represents today the most
effective strategy to prevent the disease.